WCC Biomedical is a leading CDMO company from Taiwan, specializing in the development and mass production of microarray patches. Our annual production capacity reaches 10 million patches, with a yield rate of approximately 95%. We have been invited to several prominent global events, including the BARDA Vaccine Innovation Forum and the Microneedles Conference 2025. WCC is also the only company in Taiwan recognized by PATH for its significant contributions to this field.
Wavesplitter Technologies, Inc.
WaveSplitter is fiber / laser optic product R&D and manufacturing company based in Taiwan. We support our customers around the world with competitive prices, high quality products, and wide range of the products. Such as DFB Laser, High power CW Laser, XGSPON TO-CAN/BOSA/QOSA, AOC, DAC, transceivers and all passive components.